NDC 42658-152-04 - Olanzapine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42658-152
- Requested NDC
- 42658-152-04
- Package NDCs from labels
- 42658-152-01, 42658-152-04, 42658-152-07
- Manufacturer
- Hisun Pharmaceuticals USA, Inc.
- Effective date
- 2024-01-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Olanzapine - Hisun Pharmaceuticals USA, Inc. | Hisun Pharmaceuticals USA, Inc. | 2024-01-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42658-152-01 | Olanzapine | 225 mg in 1 BOTTLE | TABLET | 225 | 1 | |
| 42658-152-04 | Olanzapine | 675 mg in 1 BOTTLE | TABLET | 675 | 1 | |
| 42658-152-07 | Olanzapine | 3750 mg in 1 BOTTLE | TABLET | 3750 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Olanzapine | OLANZAPINE | Teva Pharmaceuticals USA, Inc. | dd0b2525-4e2f-44fc-9302-0ae4ebb1e135 | 2026-02-27 | Boxed warning, Warnings, Adverse reactions | 312076 351108 351107 314155 N7U69T4SZR |
| Olanzapine | OLANZAPINE | Sandoz Inc | c44a96cc-817d-4eb5-a13a-00977f76e666 | 2026-02-26 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | American Health Packaging | c0d705bf-b719-4c7b-b83d-c17d41cbbfad | 2026-02-20 | Boxed warning, Warnings, Adverse reactions | 283639 312077 N7U69T4SZR |
| Olanzapine | OLANZAPINE | Sandoz Inc | 1e9666ef-4271-4834-8496-ccb3125d83db | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| OLANZAPINE | OLANZAPINE | Eugia US LLC | 9c745e2e-89d3-44d4-906e-704705c33310 | 2026-02-17 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Aurobindo Pharma Limited | 636665be-9d7e-443a-8134-e8cc47e6ba24 | 2026-02-10 | Boxed warning, Warnings, Adverse reactions | 200034 283639 312079 312077 314154 312078 N7U69T4SZR |
| LYBALVI | OLANZAPINE AND SAMIDORPHAN L-MALATE | Alkermes, Inc. | 32ffddd1-4e2b-45d9-9b36-bb730167ec80 | 2026-01-31 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Coupler LLC | 495efc49-7cdb-4b9e-e063-6394a90a547e | 2026-01-27 | Boxed warning, Warnings, Adverse reactions | 312077 N7U69T4SZR |
| Olanzapine | OLANZAPINE | Ascend Laboratories, LLC | e8626e68-088d-47ff-bf06-489a778815aa | 2025-12-23 | Boxed warning, Warnings, Adverse reactions | 200034 283639 312079 312077 314154 312078 N7U69T4SZR |
| Olanzapine and Fluoxetine | OLANZAPINE AND FUOXETINE | Par Health USA, LLC | 2f6ceda3-3edc-4427-98a6-23e3c930c44d | 2025-12-10 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Apotex Corp. | 3347d1c8-04c9-5ce1-8cda-b38e0412b709 | 2025-11-18 | Boxed warning, Warnings, Adverse reactions | 200034 283639 312079 312077 314154 312078 N7U69T4SZR |
| Olanzapine | OLANZAPINE | Coupler LLC | 42d9ad47-52cc-ad11-e063-6394a90aedca | 2025-11-05 | Boxed warning, Warnings, Adverse reactions | 200034 N7U69T4SZR |
| Olanzapine | OLANZAPINE | Qilu Pharmaceutical Co., Ltd. | 12ce860a-6f22-4db6-8acf-786b40f5a5a5 | 2025-10-30 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | American Health Packaging | 75616c31-8fed-4014-a9f2-4a028eccd586 | 2025-10-20 | Boxed warning, Warnings, Adverse reactions | 200034 314154 312078 N7U69T4SZR |
| Olanzapine and Fluoxetine | OLANZAPINE AND FLUOXETINE | AvKARE | f5f78ed2-4640-8528-c51c-d7bffa045d48 | 2025-10-15 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Coupler LLC | 40187874-447a-de20-e063-6394a90aafe7 | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | 283639 N7U69T4SZR |
| Olanzapine | OLANZAPINE | Coupler LLC | 3ed78a7d-4014-d280-e063-6294a90a8ee9 | 2025-09-15 | Boxed warning, Warnings, Adverse reactions | 314154 N7U69T4SZR |
| Olanzapine | OLANZAPINE | Preferred Pharmaceuticals Inc. | cfc0f187-d3ff-4bbb-9129-0e94c6eda0ee | 2025-09-05 | Boxed warning, Warnings, Adverse reactions | 200034 N7U69T4SZR |
| Olanzapine Intramuscular | OLANZAPINE | PAI Holdings, LLC dba PAI Pharma | 9d9f25d5-4513-434a-a37a-392a0c978f2e | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | N7U69T4SZR |
| Olanzapine | OLANZAPINE | Coupler LLC | 37c88965-c51d-946d-e063-6394a90a012c | 2025-06-17 | Boxed warning, Warnings, Adverse reactions | 312076 N7U69T4SZR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.